The estimated prevalence and incidence of late stage age related macular degeneration in the UK (Q35897705)

11 August 2017

The estimated prevalence and incidence of late stage age related macular degeneration in the UK (English)

1 reference

age related macular degeneration

11 August 2017

1 reference

Christopher G Owen

1

0 references

Alicja R Rudnicka

object named as

Alicja R Rudnicka

6

0 references

author name string

Zakariya Jarrar

2

1 reference

11 August 2017

Richard Wormald

3

1 reference

11 August 2017

Derek G Cook

4

1 reference

11 August 2017

Astrid E Fletcher

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

13 February 2012

1 reference

British Journal of Ophthalmology

11 August 2017

1 reference

11 August 2017

96

1 reference

11 August 2017

5

1 reference

11 August 2017

752-756

1 reference

Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Smoking and age-related macular degeneration: a review of association.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Prevalence of age-related macular degeneration in the United States

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Epidemiology of age-related maculopathy: a review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Estimating incidence from age-specific prevalence in glaucoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

The Wisconsin age-related maculopathy grading system

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Macular disease in an elderly population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Mortality and ocular diseases: the Beijing Eye Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329633

A study of the prevalence of eye disease in the elderly in an English community

24 September 2018

1 reference

12 December 2020

The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent

1 reference

12 December 2020

Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration

1 reference

12 December 2020

Clinical update: new treatments for age-related macular degeneration

1 reference

12 December 2020

Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy

1 reference

12 December 2020

Incidence and progression rates of age-related maculopathy: the Rotterdam Study

1 reference

12 December 2020

10.1136/BJOPHTHALMOL-2011-301109

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22329913

1 reference